The MELD-XI score predicts 3-year mortality in patients with chronic heart failure

Zebin Lin1, Xia Liu2,3,4, Li Xiao5

  • 1Department of Geriatrics, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, China.

Abstract

Insights

The MELD-XI score can predict long-term mortality risk in hospitalized patients with chronic heart failure. An elevated MELD-XI score at admission indicates a poorer prognosis within three years.

Area of Science:

  • Cardiology
  • Nephrology
  • Geriatrics

Background:

  • Chronic heart failure (CHF) is a significant cause of morbidity and mortality.
  • Predictive tools for long-term prognosis in hospitalized CHF patients are crucial for clinical management.
  • The prognostic value of the Model for End-Stage Liver Disease-XI (MELD-XI) score in CHF is not well-established.

Purpose of the Study:

  • To investigate the long-term prognostic relationship between the MELD-XI score and all-cause mortality in hospitalized patients with chronic heart failure.
  • To assess the predictive accuracy of the MELD-XI score for 3-year mortality in this patient population.

Main Methods:

  • Retrospective cohort study including 400 hospitalized patients with chronic heart failure.
  • Utilized Cox and lasso regression for variable selection and prognostic model development.
  • Kaplan-Meier survival analysis and log-rank tests were employed to evaluate survival outcomes and the prognostic impact of MELD-XI score.

Main Results:

  • Elevated MELD-XI score at baseline was significantly associated with increased 3-year all-cause mortality (HR 3.19, P < 0.001; adjusted HR 1.79, P = 0.020).
  • The MELD-XI score demonstrated prognostic value even in patients without chronic kidney disease (CKD).
  • Six key variables (NT-proBNP, BUN, RDW CV, Na+, prealbumin) were identified as significant predictors.

Conclusions:

  • The MELD-XI score at admission is a valuable predictor of poor long-term prognosis in hospitalized patients with chronic heart failure.
  • This score can aid in risk stratification and clinical decision-making for CHF patients.
  • Further research may explore integration of MELD-XI into existing CHF risk models.